Use of [11C]acetate and [15O]O2 PET for the assessment of myocardial oxygen utilization in patients with chronic myocardial infarction

Carbon-11 acetate positron emission tomography (PET) has been widely used to assess regional oxidative metabolism of the heart. However, the accuracy of [11C]acetate PET in assessing oxidative metabolism in infarcted myocardium remains controversial. Thirteen patients with stable coronary artery disease and old myocardial infarction were studied. The 15O-based PET studies yielded regional blood flow (rMBF, ml/min/g) and oxygen consumption (rMMRO2, ml/min/g), which was compared with the myocardial clearance rate constant (kmono) of [11C]acetate in segments with rMBF≥75% (group A), 50%–74% (group B) or <50% (group C) of the normal reference segment. Mean MBF was 0.96±0.08 ml/g/min in group A, 0.67±0.06 ml/g/min in group B and 0.42±0.07 ml/g/min in group C segments. The segmental rMMRO2 correlated linearly with kmono (r=0.89, P<0.001, y=0.61x+0.026). The kmono/rMMRO2 ratio was comparable in the group A and B segments (0.99±0.19 vs 1.07±0.21, P=NS). However, the ratio was significantly higher in the group C segments (1.28±0.35, P=0.037). It is concluded that kmono of [11C]acetate correlates linearly with rMMRO2 determined by [15O]O2 inhalation. However, kmono appears to yield higher rMMRO2 estimates than the [15O]O2 method in low-flow areas.

[1]  V. Pike,et al.  Preparation of [1-11C]acetate--an agent for the study of myocardial metabolism by positron emission tomography. , 1982, The International journal of applied radiation and isotopes.

[2]  I. Kanno,et al.  Error Analysis of a Quantitative Cerebral Blood Flow Measurement Using H215O Autoradiography and Positron Emission Tomography, with Respect to the Dispersion of the Input Function , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  B E Sobel,et al.  Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. , 1987, Circulation.

[4]  F Shishido,et al.  Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. , 1988, Circulation.

[5]  P. Herrero,et al.  Quantitation of myocardial blood flow with H2 15O and positron emission tomography: assessment and error analysis of a mathematical approach. , 1989, Journal of computer assisted tomography.

[6]  M. Walsh,et al.  Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  M. Walsh,et al.  Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  M E Phelps,et al.  Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography. , 1989, Circulation.

[9]  S. Bergmann,et al.  Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  G. Neat,et al.  Interrelations between coronary artery pressure, myocardial metabolism and coronary blood flow. , 1990, Journal of molecular and cellular cardiology.

[11]  H R Schelbert,et al.  Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. , 1990, Circulation.

[12]  H. Iida,et al.  Myocardial tissue fraction--correction for partial volume effects and measure of tissue viability. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  A. Lammertsma,et al.  Preoperative Prediction of the Outcome of Coronary Revascularization Using Positron Emission Tomography , 1992, Circulation.

[14]  R. Gropler,et al.  Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. , 1992, Journal of the American College of Cardiology.

[15]  A. Bol,et al.  Regional Oxidative Metabolism in Patients After Recovery From Reperfused Anterior Myocardial Infarction: Relation to Regional Blood Flow and Glucose Uptake , 1992, Circulation.

[16]  A. Lammertsma,et al.  Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  U. Ruotsalainen,et al.  Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  R. Gropler,et al.  Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. , 1993, Journal of the American College of Cardiology.

[19]  John C. Clark,et al.  Radiochemistry automation for PET , 1993 .

[20]  M. Phelps,et al.  Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. , 1993, Circulation.

[21]  N. Alpert,et al.  Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. , 1994, Journal of the American College of Cardiology.

[22]  A. Lammertsma,et al.  Noninvasive quantification of regional myocardial metabolic rate of oxygen by 15O2 inhalation and positron emission tomography. Experimental validation. , 1996, Circulation.

[23]  J. Viikari,et al.  Coronary flow reserve is impaired in young men with familial hypercholesterolemia. , 1996, Journal of the American College of Cardiology.

[24]  T Jones,et al.  Noninvasive quantification of regional myocardial metabolic rate for oxygen by use of 15O2 inhalation and positron emission tomography. Theory, error analysis, and application in humans. , 1996, Circulation.

[25]  N. Tamaki,et al.  Noninvasive assessment of myocardial viability by positron emission tomography with 11C acetate in patients with old myocardial infarction. Usefulness of low-dose dobutamine infusion. , 1996, Circulation.

[26]  K. Någren,et al.  Myocardial efficiency during calcium sensitization with levosimendan: A noninvasive study with positron emission tomography and echocardiography in healthy volunteers , 1997, Clinical pharmacology and therapeutics.

[27]  A. Bockisch,et al.  Positron emission tomography analysis of [1-(11)C] acetate kinetics in short-term hibernating myocardium. , 1998, Circulation.